JBIO

Conviction 47HealthcareScan · Thu, Sep 24, 2026

Jade Biosciences, Inc. (JBIO) closed at $14.72 (+0.03%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 23, RS Rating 94, -45.2% from its 52-week high, +3.9% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

JBIO$14.72+0.03%

ResistanceSupportVol 14

Vol MA14 1.35M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Jade Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.jadebiosciences.com ↗

Price14.72

Change+0.03%

Gap+0.61%

Rel volume3.73×

Avg volume1.14M

Avg $ vol20.08M

SMA 2018.52

SMA 5020.18

SMA 20018.34

Price vs 50-27.09%

Price vs 200-19.75%

MA stackmixed

50/200 cross—

Supertrenddown · 18.32

RSI (14)23

MACD hist-0.37

MACD cross—

Stoch %K / %D4 / 6

ADX (14)31

+DI / −DI8 / 32

RSI divergence—

MACD divergence—

ATR %8.28%

ADR %6.06%

52w high26.85

52w low8.06

From 52w high-45.20%

Above 52w low+82.57%

New 52w highNo

SqueezeOff

Bollinger width44.75%

%B0.04

Donchian pos3.38%

Donchian high22.00

Donchian low14.46

AVWAP (52w high)19.88

vs AVWAP high-25.98%

AVWAP (52w low)18.32

vs AVWAP low-19.70%

OBV trendDown

Chaikin MF (20)-0.36

Today vs 20d3.73×

Avg vol (14d)1.35M

Avg vol (20d)1.14M

Avg $ vol (20d)20.08M

Market cap935.84M

RS Rating94 / 99

RS 3m (vs SPY)-37.02%

RS 6m (vs SPY)-11.33%

RS line new highNo

Trend template4/8

Technical rank22.9

1 week-14.15%

1 month-32.62%

3 months-32.53%

6 months+5.48%

1 year+93.36%

YTD+3.92%

P/E-7.35

P/B2.13

P/S—

P/FCF-9.86

EPS-3.19

Div yield—

ROE-28.96%

ROA-26.99%

Debt/Eq—

Current14.93

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-82.99%

Price target50.50

Target upside243.19%

Analyst ratingBuy

Institutional122.78%

Ent. value828.59M

Revenue—

Net income-55.77M

Gross profit—

Free cash flow-94.89M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out49.36M

Employees55

ListedTue, Apr 29, 2025

Free float41.37M

Float %83.9%

Short interest9.99M

Days to cover16.5d

Short volume43.8%

Squeeze score83 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.76 vs −$0.66

Last surprise-15.2% miss

Setup gradeC

Conviction47 / 100

Pattern quality—

Tech rank22.9 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance23.70

Support17.36

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jul 7 – Aug 11
5 scans
→
Breaking out now
Aug 12
1 scan

Congress activity

Disclosed STOCK Act trades in JBIO

All disclosures →

No recent disclosed trades by Congress in JBIO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in JBIO

No recent insider (Form 4) filings in JBIO. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in JBIO · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.